We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MIV Therapeutics, a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, will unveil technology to address multiple revenue opportunities in the $23 billion orthopedic device market at the upcoming World Orthopedic Organization (SICOT) conference in Buenos Aires, later this month.
Bayer HealthCare, Diagnostics Division, a member of the Bayer Group, announced the availability of its new Tnl-Ultra Troponin assay on ADVIA Centaur CP Immunoassay system.
Frost & Sullivan selected Biosense Webster, Inc. as the recipient of its 2006 Excellence in Technology Award in the cardiac rhythm management market for its longstanding commitment to developing clinically safe and complete cardiac ablation systems.
Micell Technologies announced an expansion of its license agreement for using supercritical fluids for creating medical device surface modifications with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.
Medical imaging equipment maker Hologic Inc. said Thursday it gave final approval and completed its settlement with the Federal Trade Commission over an intellectual property dispute with Siemens AG.
AdvaMed President and CEO Steve Ubl Aug. 10 responded to proposed rules for ambulatory surgery center (ASC) reimbursement, the Outpatient Prospective Payment System and the Physician Fee Schedule issued by the Centers for Medicare & Medicaid Services (CMS) Aug. 8.
The FDA Aug. 10 responded to a recent study article that found a more than 20 percent recall rate over a 10-year period for automated external defibrillators (AEDs), and pointed to a need for better tracking of the devices.